16 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Design, synthesis, protein-ligand X-ray structure, and biological evaluation of a series of novel macrocyclic human immunodeficiency virus-1 protease inhibitors to combat drug resistance.![BDB](/images/logo_bindingdb.png)
![BDB](/images/logo_bindingdb.png)
Purdue University
Design of HIV-1 protease inhibitors with pyrrolidinones and oxazolidinones as novel P1'-ligands to enhance backbone-binding interactions with protease: synthesis, biological evaluation, and protein-ligand X-ray studies.![BDB](/images/logo_bindingdb.png)
![BDB](/images/logo_bindingdb.png)
Purdue University
Flexible cyclic ethers/polyethers as novel P2-ligands for HIV-1 protease inhibitors: design, synthesis, biological evaluation, and protein-ligand X-ray studies.![BDB](/images/logo_bindingdb.png)
![BDB](/images/logo_bindingdb.png)
Purdue University
Molecular recognition of macrocyclic peptidomimetic inhibitors by HIV-1 protease.![BDB](/images/logo_bindingdb.png)
![BDB](/images/logo_bindingdb.png)
University of Queensland
Structure-Based Design of Novel HIV-1 Protease Inhibitors To Combat Drug Resistance.![BDB](/images/logo_bindingdb.png)
![BDB](/images/logo_bindingdb.png)
Purdue University
Design and synthesis of novel HIV-1 protease inhibitors incorporating oxyindoles as the P2'-ligands.![BDB](/images/logo_bindingdb.png)
![BDB](/images/logo_bindingdb.png)
Purdue University
Potent HIV protease inhibitors incorporating high-affinity P2-ligands and (R)-(hydroxyethylamino)sulfonamide isostere.![BDB](/images/logo_bindingdb.png)
![BDB](/images/logo_bindingdb.png)
University of Illinois At Chicago
Structure-based design: synthesis and biological evaluation of a series of novel cycloamide-derived HIV-1 protease inhibitors.![BDB](/images/logo_bindingdb.png)
![BDB](/images/logo_bindingdb.png)
University of Illinois At Chicago
Novel cyclourethane-derived HIV protease inhibitors: a ring-closing olefin metathesis based strategy.![BDB](/images/logo_bindingdb.png)
![BDB](/images/logo_bindingdb.png)
University of Illinois At Chicago
Novel spirocyclic pyrrolidones as P2/P1 mimetics in potent inhibitors of HIV-1 protease.![BDB](/images/logo_bindingdb.png)
![BDB](/images/logo_bindingdb.png)
Glaxosmithkline
Novel inhibitors of HIV protease: design, synthesis and biological evaluation of picomolar inhibitors containing cyclic P1/P2 scaffolds.![BDB](/images/logo_bindingdb.png)
![BDB](/images/logo_bindingdb.png)
Glaxosmithkline
Discovery of potent pyrrolidone-based HIV-1 protease inhibitors with enhanced drug-like properties.![BDB](/images/logo_bindingdb.png)
![BDB](/images/logo_bindingdb.png)
Glaxosmithkline
Potent inhibitors of the HIV-1 protease incorporating cyclic urea P1-P2 scaffold.![BDB](/images/logo_bindingdb.png)
![BDB](/images/logo_bindingdb.png)
Glaxosmithkline